InsidersTradesSigma
Track the 兰卫医学 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 兰卫医学 has logged 3 insider filings. Market capitalisation: €3.4bn. The latest transaction was reported on 26 March 2024 (Sale). Among the most active insiders: 孙林洁. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,424 of 28,797 companies
35.1
score / 100
Value35
Quality35
FCF yld6.1%
Earn yld-0.9%
EV/EBITDA37.5x
ROE1.8%
Gross mgn24%
Net mgn-2.1%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 March 2024
About 兰卫医学
兰卫医学 is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the XSHE market.